CTNB1 AS A MARKER FOR ENDOMETRIAL CANCER

Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples.The invention also provides kits comprising means for detecting said proteins...

Full description

Saved in:
Bibliographic Details
Main Authors LESUR, ANTOINE, MARTINEZ GARCIA, ELENA, DOMON, BRUNO, GIL MORENO, ANTONIO, CAMPOY MONCAYO, IRENE, COLAS ORTEGA, EVA, REVENTOS PUIGJANER, JAUME
Format Patent
LanguageEnglish
French
Published 24.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-acces isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples.The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease. La présente invention concerne une méthode de diagnostic et de pronostic du cancer de l'endomètre dans des échantillons isolés faciles d'accès par détection du niveau d'expression d'une ou de plusieurs protéines. En particulier, provenant d'échantillons de fluide utérin. L'invention concerne également des kits comprenant des moyens pour détecter lesdites protéines pour une utilisation dans le diagnostic et le pronostic de la maladie.
Bibliography:Application Number: CA20183070041